Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)
CNY 16.08
(0.06%)
CNY 16.08
(0.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 74.18 Million CNY | -11.0% |
| 2022 | 130.84 Million CNY | -42.73% |
| 2021 | 228.46 Million CNY | -51.76% |
| 2020 | 473.57 Million CNY | 145.98% |
| 2019 | 192.52 Million CNY | 16.47% |
| 2018 | 165.3 Million CNY | -14.04% |
| 2017 | 192.31 Million CNY | 12.07% |
| 2016 | 171.6 Million CNY | -37.35% |
| 2015 | 273.92 Million CNY | 100.18% |
| 2014 | 136.83 Million CNY | 0.83% |
| 2013 | 135.71 Million CNY | -40.48% |
| 2012 | 227.99 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 34.87 Million CNY | 66.79% |
| 2024 Q3 | 46.04 Million CNY | 36.37% |
| 2024 Q2 | 33.76 Million CNY | -3.17% |
| 2023 Q4 | 20.9 Million CNY | -35.7% |
| 2023 FY | 116.45 Million CNY | -11.0% |
| 2023 Q1 | 31.72 Million CNY | 369.27% |
| 2023 Q2 | 31.3 Million CNY | -1.32% |
| 2023 Q3 | 32.51 Million CNY | 3.87% |
| 2022 Q3 | 33.68 Million CNY | -15.26% |
| 2022 Q1 | 50.65 Million CNY | -15.58% |
| 2022 Q2 | 39.75 Million CNY | -21.52% |
| 2022 FY | 130.84 Million CNY | -42.73% |
| 2022 Q4 | 6.76 Million CNY | -79.93% |
| 2021 Q2 | 58.6 Million CNY | 8.37% |
| 2021 Q4 | 59.99 Million CNY | 7.56% |
| 2021 FY | 228.46 Million CNY | -51.76% |
| 2021 Q1 | 54.07 Million CNY | -40.12% |
| 2021 Q3 | 55.78 Million CNY | -4.81% |
| 2020 FY | 473.57 Million CNY | 145.98% |
| 2020 Q4 | 90.3 Million CNY | -22.17% |
| 2020 Q3 | 116.03 Million CNY | -27.88% |
| 2020 Q2 | 160.88 Million CNY | 51.29% |
| 2020 Q1 | 106.34 Million CNY | 67.08% |
| 2019 Q1 | 40.62 Million CNY | 7.86% |
| 2019 Q2 | 43.42 Million CNY | 6.89% |
| 2019 Q4 | 63.64 Million CNY | 41.97% |
| 2019 Q3 | 44.83 Million CNY | 3.25% |
| 2019 FY | 192.52 Million CNY | 16.47% |
| 2018 Q1 | 55.17 Million CNY | -10.32% |
| 2018 Q3 | 42.87 Million CNY | 44.91% |
| 2018 Q4 | 37.66 Million CNY | -12.16% |
| 2018 FY | 165.3 Million CNY | -14.04% |
| 2018 Q2 | 29.59 Million CNY | -46.37% |
| 2017 FY | 192.31 Million CNY | 12.07% |
| 2017 Q2 | 46.54 Million CNY | 24.01% |
| 2017 Q4 | 61.52 Million CNY | 31.68% |
| 2017 Q1 | 37.53 Million CNY | 15.97% |
| 2017 Q3 | 46.72 Million CNY | 0.39% |
| 2016 Q3 | 39.65 Million CNY | 0.0% |
| 2016 FY | 171.6 Million CNY | -37.35% |
| 2016 Q4 | 32.36 Million CNY | -18.38% |
| 2015 Q2 | 91.01 Million CNY | 0.0% |
| 2015 Q1 | 91.01 Million CNY | 0.0% |
| 2015 FY | 273.92 Million CNY | 100.18% |
| 2014 FY | 136.83 Million CNY | 0.83% |
| 2013 FY | 135.71 Million CNY | -40.48% |
| 2012 FY | 227.99 Million CNY | 0.0% |